A dengue DNA vaccine formulated with Vaxfectin(®) is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits

A tetravalent DNA vaccine formulated with Vaxfectin adjuvant was shown to elicit high levels of neutralizing antibody against all four dengue virus serotypes (Porter et al.,(16)), warranting further testing in humans. In preparation for a phase 1 clinical testing, the vaccine and the adjuvant were m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Raviprakash, Kanakatte, Luke, Thomas, Doukas, John, Danko, Janine, Porter, Kevin, Burgess, Timothy, Kochel, Tadeusz
Materialtyp: Artigo
Språk:Inglês
Publicerad: Landes Bioscience 2012
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3656063/
https://ncbi.nlm.nih.gov/pubmed/23032166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.21806
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk